Alan Meisel | University of Pittsburgh (original) (raw)
Papers by Alan Meisel
Clinical trials (London, England), 2017
Data monitoring committees are responsible for safeguarding the interests of study participants a... more Data monitoring committees are responsible for safeguarding the interests of study participants and assuring the integrity and credibility of clinical trials. The independence of data monitoring committees from sponsors and investigators is essential in achieving this mission. Creative approaches are needed to address ongoing and emerging challenges that potentially threaten data monitoring committees' independence and effectiveness. An expert panel of representatives from academia, industry and government sponsors, and regulatory agencies discussed these challenges and proposed best practices and operating principles for effective functioning of contemporary data monitoring committees. Prospective data monitoring committee members need better training. Options could include didactic instruction as well as apprenticeships to provide real-world experience. Data monitoring committee members should be protected against legal liability arising from their service. While avoiding brea...
Bookmarks Related papers MentionsView impact
Prehospital and Disaster Medicine, 1985
Medicine has made great advances in the past decade, and is now opening the frontiers of brain re... more Medicine has made great advances in the past decade, and is now opening the frontiers of brain resuscitation. Coinciding with the advances in medicine, society has witnessed great changes. There is an increasing awareness of patients' rights, an increasing desire for self determination, a rejection of the once-accepted paternal role of the physician, and an increasing willingness to challenge physicians in the courts. At the same time, government regulation of biomedical research has been expanding rapidly. The origin of this regulation dates back to the post-World War II Nuremburg trials. In 1974, the National Research Act established the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The evolving concern about human experimentation has led to the current Department of Health and Human Services (DHHS) and the Federal Drug Administration (FDA) regulations which became effective July 27,1981. All biomedical research supported by fe...
Bookmarks Related papers MentionsView impact
Bioetica Para Clinicos 1999 Isbn 84 921418 9 1 Pags 151 162, 1999
Bookmarks Related papers MentionsView impact
Journal of the American Academy of Psychiatry and the Law Online, Feb 1, 1986
Bookmarks Related papers MentionsView impact
Nebraska Law Review, Feb 1, 1977
Bookmarks Related papers MentionsView impact
Journal of Health Care Law and Policy, 1999
Bookmarks Related papers MentionsView impact
Journal of the American Academy of Psychiatry and the Law Online, Feb 1, 1980
Bookmarks Related papers MentionsView impact
The Journal of Clinical Ethics, Feb 1, 1990
Bookmarks Related papers MentionsView impact
... Welcome: Dr. Donald S. Burke Panelists: Susan M. Reverby, PhD, Wellesley College, and Sue E. ... more ... Welcome: Dr. Donald S. Burke Panelists: Susan M. Reverby, PhD, Wellesley College, and Sue E. Lederer, PhD, University of Wisconsin Moderator: Alan Meisel, JD, University of Pittsburgh School of Law, Professor of Law and Psychiatry, and Dickie, McCamey & Chilcote ...
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
Archives of Internal Medicine, Aug 1, 1991
There are a number of myths about what the law permits concerning the termination of life support... more There are a number of myths about what the law permits concerning the termination of life support, some of which spring from a fundamental misconception of what law is. A serious misunderstanding of the law can lead to tragic results for physicians, health care institutions, patients, and families. These misunderstandings are (1) anything that is not specifically permitted by law is prohibited; (2) termination of life support is murder or suicide; (3) a patient must be terminally ill for life support to be stopped; (4) it is permissible to terminate extraordinary treatments, but not ordinary ones; (5) it is permissible to withhold treatment, but once started, it must be continued; (6) stopping tube feeding is legally different from stopping other treatments; (7) termination of life support requires going to court; and (8) living wills are not legal.
Bookmarks Related papers MentionsView impact
American Journal of Psychiatry, Oct 7, 2014
Bookmarks Related papers MentionsView impact
Biomedecine Pharmacotherapy, Feb 1, 1983
Bookmarks Related papers MentionsView impact
International Journal of Law and Psychiatry, 1981
Bookmarks Related papers MentionsView impact
Houston Law Review University of Houston, Feb 1, 1999
ARTICLE MANAGED CARE, AUTONOMY, AND DECISIONMAKING AT THE END OF LIFE Alan MeiseC Table of Conten... more ARTICLE MANAGED CARE, AUTONOMY, AND DECISIONMAKING AT THE END OF LIFE Alan MeiseC Table of Contents I. Introduction 1394 II. Autonomy and End-of-Life Decisionmaking 1397 A. The Development of the Law of Informed Consent 1399 B. The Right to Refuse ...
Bookmarks Related papers MentionsView impact
The Journal of Family Practice, Mar 1, 1985
The mentally incapacitated patient is frequently encountered in the general medical hospital. Inc... more The mentally incapacitated patient is frequently encountered in the general medical hospital. Incapacity is the clinical state in which a patient is unable to participate in a meaningful way in medical decisions. Mentally incapacitated patients relinquish the authority, that is the competent patient's right, to choose among professionally acceptable alternative treatments. Such patients, therefore, require a surrogate decision-maker. There are certain clinical situations in which questions of incapacity are especially important to consider. In a study for the President's Commission for the Study of Ethical Problems in Medical Biomedical and Behavioral Research, the most common problem in recognizing incapacity was found with previously capable patients who became transiently incapacitated during the course of hospitalization. Questions of incapacity or the authority of surrogate decision-makers also arose with comatose, mentally retarded, mentally ill, and physically handicapped patients. While standards to determine capacity remain unclear, a practical approach is to demonstrate that a patient is able to describe the physician's view of the situation and to understand the physician's opinion as to the best intervention. When a patient is deemed to be incapacitated, the physician should turn to family members, whenever possible, to make decisions.
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
University of Pittsburgh Law Review University of Pittsburgh School of Law, Feb 1, 1980
1. Univ Pittsbg Law Rev. 1980 Spring;41(3):407-564. Informed consent to medical treatment: an ana... more 1. Univ Pittsbg Law Rev. 1980 Spring;41(3):407-564. Informed consent to medical treatment: an analysis of recent legislation. Meisel A, Kabnick LD. PMID: 11665252 [PubMed - indexed for MEDLINE]. MeSH Terms: Consent ...
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
Annals of Internal Medicine, Apr 1, 1985
As computer programs are used with increasing frequency in the clinical setting, ethicists, lawye... more As computer programs are used with increasing frequency in the clinical setting, ethicists, lawyers, computer scientists, clinicians, and patients must confront a group of problems: In what situations is it appropriate to use a medical computer program? Who should use these programs and how should they be used? What is the legal status of a computer program that provides medical advice? Can a proper balance be achieved between confidentiality of patient information and shared access to records by health care personnel? How can regulatory agencies, physicians, and patients determine if a program is safe for human use? Will programs be able to communicate with users well enough to prevent clinically harmful misunderstandings? Because few if any definitive answers are yet available, these questions remain the subject of much discussion.
Bookmarks Related papers MentionsView impact
Clinical trials (London, England), 2017
Data monitoring committees are responsible for safeguarding the interests of study participants a... more Data monitoring committees are responsible for safeguarding the interests of study participants and assuring the integrity and credibility of clinical trials. The independence of data monitoring committees from sponsors and investigators is essential in achieving this mission. Creative approaches are needed to address ongoing and emerging challenges that potentially threaten data monitoring committees' independence and effectiveness. An expert panel of representatives from academia, industry and government sponsors, and regulatory agencies discussed these challenges and proposed best practices and operating principles for effective functioning of contemporary data monitoring committees. Prospective data monitoring committee members need better training. Options could include didactic instruction as well as apprenticeships to provide real-world experience. Data monitoring committee members should be protected against legal liability arising from their service. While avoiding brea...
Bookmarks Related papers MentionsView impact
Prehospital and Disaster Medicine, 1985
Medicine has made great advances in the past decade, and is now opening the frontiers of brain re... more Medicine has made great advances in the past decade, and is now opening the frontiers of brain resuscitation. Coinciding with the advances in medicine, society has witnessed great changes. There is an increasing awareness of patients' rights, an increasing desire for self determination, a rejection of the once-accepted paternal role of the physician, and an increasing willingness to challenge physicians in the courts. At the same time, government regulation of biomedical research has been expanding rapidly. The origin of this regulation dates back to the post-World War II Nuremburg trials. In 1974, the National Research Act established the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The evolving concern about human experimentation has led to the current Department of Health and Human Services (DHHS) and the Federal Drug Administration (FDA) regulations which became effective July 27,1981. All biomedical research supported by fe...
Bookmarks Related papers MentionsView impact
Bioetica Para Clinicos 1999 Isbn 84 921418 9 1 Pags 151 162, 1999
Bookmarks Related papers MentionsView impact
Journal of the American Academy of Psychiatry and the Law Online, Feb 1, 1986
Bookmarks Related papers MentionsView impact
Nebraska Law Review, Feb 1, 1977
Bookmarks Related papers MentionsView impact
Journal of Health Care Law and Policy, 1999
Bookmarks Related papers MentionsView impact
Journal of the American Academy of Psychiatry and the Law Online, Feb 1, 1980
Bookmarks Related papers MentionsView impact
The Journal of Clinical Ethics, Feb 1, 1990
Bookmarks Related papers MentionsView impact
... Welcome: Dr. Donald S. Burke Panelists: Susan M. Reverby, PhD, Wellesley College, and Sue E. ... more ... Welcome: Dr. Donald S. Burke Panelists: Susan M. Reverby, PhD, Wellesley College, and Sue E. Lederer, PhD, University of Wisconsin Moderator: Alan Meisel, JD, University of Pittsburgh School of Law, Professor of Law and Psychiatry, and Dickie, McCamey & Chilcote ...
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
Archives of Internal Medicine, Aug 1, 1991
There are a number of myths about what the law permits concerning the termination of life support... more There are a number of myths about what the law permits concerning the termination of life support, some of which spring from a fundamental misconception of what law is. A serious misunderstanding of the law can lead to tragic results for physicians, health care institutions, patients, and families. These misunderstandings are (1) anything that is not specifically permitted by law is prohibited; (2) termination of life support is murder or suicide; (3) a patient must be terminally ill for life support to be stopped; (4) it is permissible to terminate extraordinary treatments, but not ordinary ones; (5) it is permissible to withhold treatment, but once started, it must be continued; (6) stopping tube feeding is legally different from stopping other treatments; (7) termination of life support requires going to court; and (8) living wills are not legal.
Bookmarks Related papers MentionsView impact
American Journal of Psychiatry, Oct 7, 2014
Bookmarks Related papers MentionsView impact
Biomedecine Pharmacotherapy, Feb 1, 1983
Bookmarks Related papers MentionsView impact
International Journal of Law and Psychiatry, 1981
Bookmarks Related papers MentionsView impact
Houston Law Review University of Houston, Feb 1, 1999
ARTICLE MANAGED CARE, AUTONOMY, AND DECISIONMAKING AT THE END OF LIFE Alan MeiseC Table of Conten... more ARTICLE MANAGED CARE, AUTONOMY, AND DECISIONMAKING AT THE END OF LIFE Alan MeiseC Table of Contents I. Introduction 1394 II. Autonomy and End-of-Life Decisionmaking 1397 A. The Development of the Law of Informed Consent 1399 B. The Right to Refuse ...
Bookmarks Related papers MentionsView impact
The Journal of Family Practice, Mar 1, 1985
The mentally incapacitated patient is frequently encountered in the general medical hospital. Inc... more The mentally incapacitated patient is frequently encountered in the general medical hospital. Incapacity is the clinical state in which a patient is unable to participate in a meaningful way in medical decisions. Mentally incapacitated patients relinquish the authority, that is the competent patient's right, to choose among professionally acceptable alternative treatments. Such patients, therefore, require a surrogate decision-maker. There are certain clinical situations in which questions of incapacity are especially important to consider. In a study for the President's Commission for the Study of Ethical Problems in Medical Biomedical and Behavioral Research, the most common problem in recognizing incapacity was found with previously capable patients who became transiently incapacitated during the course of hospitalization. Questions of incapacity or the authority of surrogate decision-makers also arose with comatose, mentally retarded, mentally ill, and physically handicapped patients. While standards to determine capacity remain unclear, a practical approach is to demonstrate that a patient is able to describe the physician's view of the situation and to understand the physician's opinion as to the best intervention. When a patient is deemed to be incapacitated, the physician should turn to family members, whenever possible, to make decisions.
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
University of Pittsburgh Law Review University of Pittsburgh School of Law, Feb 1, 1980
1. Univ Pittsbg Law Rev. 1980 Spring;41(3):407-564. Informed consent to medical treatment: an ana... more 1. Univ Pittsbg Law Rev. 1980 Spring;41(3):407-564. Informed consent to medical treatment: an analysis of recent legislation. Meisel A, Kabnick LD. PMID: 11665252 [PubMed - indexed for MEDLINE]. MeSH Terms: Consent ...
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
Annals of Internal Medicine, Apr 1, 1985
As computer programs are used with increasing frequency in the clinical setting, ethicists, lawye... more As computer programs are used with increasing frequency in the clinical setting, ethicists, lawyers, computer scientists, clinicians, and patients must confront a group of problems: In what situations is it appropriate to use a medical computer program? Who should use these programs and how should they be used? What is the legal status of a computer program that provides medical advice? Can a proper balance be achieved between confidentiality of patient information and shared access to records by health care personnel? How can regulatory agencies, physicians, and patients determine if a program is safe for human use? Will programs be able to communicate with users well enough to prevent clinically harmful misunderstandings? Because few if any definitive answers are yet available, these questions remain the subject of much discussion.
Bookmarks Related papers MentionsView impact